# Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 Diabetes

> **NCT00184639** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 71 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** insulin detemir

## Key facts

- **NCT ID:** NCT00184639
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08-16
- **Primary completion:** 2005-11-22
- **Final completion:** 2005-11-22
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2017-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00184639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00184639, "Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 Diabetes". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00184639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*